Michelle Arbus Interview with Business of Cannabis for Green + Silver
Michelle Arbus joined Business of Cannabis to talk about how the data that she will be presenting identifies trends among older cannabis users and what that means for medical cannabis patients.
Michelle and Noah Featured on Humble & Fred Radio
Michelle and Noah Featured on Humble & Fred Radio Newest additions to the Strainprint team- Michelle and Noah joined Humble & Fred to talk all things cannabis! Follow our Strainprint Features Playlist on YouTube to stay tuned in and up to date on what we’re doing at Strainprint.
Strainprint Technologies Continues Rapid Growth
Strainprint Technologies Ltd. Continues Rapid Growth, Welcoming Two New Senior Staff Members to the Expanding Team TORONTO, August 01, 2018 – Strainprint Technologies Ltd. (Strainprint™) – the leader in cannabis strain data and analytics – is excited to announce the addition of two key senior team members: Michelle Arbus, Vice President of Research & Insights, […]
Strainprint Technologies Ltd. Featured in The Growth Op
Recently, Strainprint Founder Stephanie Karasick was featured in The Growth Op. Here she talks about the launch of the Strainprint app that helped, and continues to help her and tens of thousands of other patients keep track of their medical marijuana dosage. Read more about Steph’s journey, and Strainprint here: https://www.thegrowthop.com/cannabis-business/cannabis-experts/when-it-comes-to-cannabis-prescriptions-sometimes-less-is-more
Strainprint Technologies Ltd. – Steph’s Story
We are proud to present the genesis of Strainprint. Steph’s story is what defines us. With her story, and 1,000’s more like it we will continue to break the stigma & pave the way for the future of the cannabis industry. Have a look at Steph’s story, and if it resonates with you, consider sharing! […]
Strainprint™ Closes USD $3 Million (Cdn.$3.8M) Series A Funding
TORONTO, May 8, 2018 /PRNewswire/ – StrainprintTM Technologies — the leader in cannabis data and analytics is pleased to announce the closing of a USD $3 Million (Cdn.$3.8 Million) non-brokered, Series A private placement. The round was led by strategic industry investor, Cesare Fazari, Chairman of Molecular Science Corp and seed investor of leading cannabis companies, Ample Organics and Hydropothecary. Mr. Fazari […]
WSU uses Strainprint Technologies Data in study
PULLMAN, WA – In a first-of-a-kind study, Washington State University scientists examined how peoples’ self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home. Their work, published this month in the Journal of Affective Disorders, suggests smoking cannabis can significantly reduce short-term levels of depression, anxiety, […]
Strainprint™ Technologies Ltd. ("Strainprint") Welcomes Three Leading Cannabinoid Physicians to its Board
Dr. Caroline MacCallum, Dr. Danial Schecter & Dr. Dean Elterman Join Strainprint’s World-Class Medical Advisory Board TORONTO, April 17, 2018 /CNW/ – Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely […]
Strainprint President & CTO, David Berg Featured in Cannabis Investing News
The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before. With the current state of cannabis working towards legalization across the globe, new channels of research are opening up across the board as an effort to rapidly catch up with a market ready to consume a product […]